Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer
-
Published:2021-07-15
Issue:2
Volume:189
Page:377-386
-
ISSN:0167-6806
-
Container-title:Breast Cancer Research and Treatment
-
language:en
-
Short-container-title:Breast Cancer Res Treat
Author:
Dent RebeccaORCID, Oliveira Mafalda, Isakoff Steven J., Im Seock-Ah, Espié Marc, Blau Sibel, Tan Antoinette R., Saura Cristina, Wongchenko Matthew J., Xu Na, Bradley Denise, Reilly Sarah-Jayne, Mani Aruna, Kim Sung-Bae, Lee K. S., Sohn J. H., Kim J. H., Seo J. H., Kim J. S., Park S., Velez M., Dakhil S., Hurvitz S., Valero V., Vidal G., Figlin R., Allison M. A. K., Chan D., Cobleigh M., Hansen V., Iannotti N., Lawler W., Salkini M., Seigel L., Romieu G., Debled M., Levy C., Hardy-Bessard A., Guiu S., Estevez L. Garcia, Villanueva R., Martin A. Gonzalez, Rovira P. Sanchez, Montaño A., Plaza M. I. Calvo, Saenz J. A. García, Garau I., Bermejo B., Alonso E. Vega, Wang H.-C., Huang C.-S., Chen S.-C., Chen Y.-H., Tseng L.-M., Wong A., Ang C. S. P., De Laurentiis M., Conte P. F., De Braud F., Montemurro F., Gianni L., Dirix L.,
Funder
F. Hoffmann-La Roche
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|